MODIFIED INSULIN WITH REDUCED IMMUNOGENICITY

Details for Australian Patent Application No. 2002256686 (hide)

Owner MERCK PATENT GMBH

Inventors CARR, Francis, J.; CARTER, Graham

Pub. Number AU-A-2002256686

PCT Pub. Number WO2002/074808

Priority 01106900.2 20.03.01 EP

Filing date 19 March 2002

Wipo publication date 3 October 2002

International Classifications

C07K 014/62 Peptides having more than 20 amino acids

C07K 007/08 Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 015/17 Mutation or genetic engineering

A61K 038/28 Medicinal preparations containing peptides - Insulins

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002256686

8 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256687-Use of binding domains of presenilins and transmembrane proteins for drug screening

2002256685-Pyrrolidine ester derivatives with oxytocin modulating acitvity